21 results
6-K
TAK
Takeda Pharmaceutical Co
14 Jan 20
Current report (foreign)
6:56am
.
In addition to Takeda’s environmental efforts, its overall commitment to ESG – including the Access to Medicines Strategy and Global Corporate Social Responsibility (CSR
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 Jun 21
Current report (foreign)
7:38am
to Planet Financial Performance Values-Based Governance Global Corporate Social Responsibility Legal Disclaimers Appendix Reconciliations 03 06 08 09 … , more than 60% of our research and development (R&D) pipeline is being developed with partners around the world. We have 16 Global Corporate Social Responsibility Program
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
to treatment and aftercare. Finally, our Global Corporate Social Responsibility (CSR) Program is designed to help achieve Sustainable Development Goals (SDGs) #3 … Corporate Social Responsibility (CSR) activities. Our flagship 13 Global CSR Program focuses on disease prevention through capacity building, and healthcare
6-K
TAK
Takeda Pharmaceutical Co
29 Jul 20
Current report (foreign)
6:07am
-responsibility/environment/commitment-to-carbon-neutrality-at-takeda
[CSR (Philanthropy) activities]
Our global corporate social responsibility (CSR
6-K
TAK
Takeda Pharmaceutical Co
11 May 21
Current report (foreign)
6:08am
to Medicines strategy and Global Corporate Social Responsibility Program – is evident through recognition by many benchmark ESG indices. For instance, Takeda
6-K
kntv 0o90e2
13 May 20
Current report (foreign)
6:03am
6-K
EX-99.1
i8g 8wc4hfsqf03hnz
14 Nov 19
Current report (foreign)
6:26am
6-K
EX-1
a3jml2d 36
27 May 20
Current report (foreign)
6:03am
6-K
EX-99.1
uzqqwohoq2p78
17 Dec 20
Current report (foreign)
6:01am
6-K
EX-99.1
84ro9w
28 May 21
Current report (foreign)
6:01am
F-4/A
rpd0n93e9hvy1x
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
cjwet8 i9l
9 Aug 19
Registration of securities (foreign)
6:27am
424B3
blk15dslq432q
14 Nov 19
Prospectus supplement
6:10am
20FR12B/A
cp9tx3o
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
DRS/A
jfqfnhnvjfus3ov tv
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B
m7fit4p ufbuja
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am